Wegovy and similar weight loss drugs may cause more side effects than currently recognized.
For each of these potential concerns, the FDA states that it is evaluating the need for regulatory action.
Its active ingredient is semaglutide, a synthetic and longer-lasting version of the hormone GLP-1.
Image: oleschwander (Shutterstock)
And this fall, Eli Lilly received approval for a tirzepatide-based obesity drug sold under the brand name Zepbound.
Whatever you call them, these drugs havedramatically changedthe landscape of obesity treatment since their arrival.
In clinical trials, theyve helped people lose substantially more weight than diet and exercise alone.
And now the FDA has formally followed suit.
So these investigations by the FDA and other health agencies could very well lead to regulatory action.
These actions would likely include further changes to the product labeling of these drugs.
News from the future, delivered to your present.
You May Also Like
Trump Is Promising to Lower Drug Prices.
Does Ozempic Really Cause Thyroid Cancer?
Does Ozempic Raise Suicide Risk?
